AE	Adverse event
ANG2	Angiopoietin-2
APC	Antigen-presenting cell
CCL2	C-C motif chemokine ligand 2
CCL20	C-C motif chemokine ligand 20
CCL22	C-C motif chemokine ligand 22
CCL28	C-C motif chemokine ligand 28
CIK	Cytokine-induced killer cell
CSF1	Colony stimulating factor 1
CTLA4	Cytotoxic T-lymphocyte-associated protein 4
CXCL12	C-X-C motif chemokine ligand 12
CXCR4	C-X-C motif chemokine receptor 4
DC	Dendritic cell
EC	Endothelial cell
EMA	Exponential moving average
FDA	Food and Drug Administration
FGFR	Fibroblast growth factor receptor
GBM	Glioblastoma multiforme
GM-CSF	Granulocyte-macrophage colony stimulating factor
HCC	Hepatocellular carcinoma
HIF-1α	Hypoxia-inducible factor 1-alpha
HPV	Human papillomavirus
ICAM1	Intercellular adhesion molecule 1
ICB	Immune checkpoint blockade
ICI	Immune checkpoint inhibitor
IDO	Indoleamine 2,3-dioxygenase
IFN-γ	Interferon-gamma
IL-10	Interleukin-10
IL-6	Interleukin-6
imDC	Immature dendritic cell
Jak2/STAT3	Janus kinase 2/Signal transducer and activator of transcription 3
MDSC	Myeloid-derived suppressive cell
MHC	Major histocompatibility complex
NF-κB	Nuclear factor κB
Nrp-1	Neuropilin 1
NSCLC	Non-small cell lung cancer
ORR	Objective response rate
OS	Overall survival
PD-1	Programmed cell death-1
PDGFR	Platelet-derived growth factor receptor
PD-L1	Programmed death ligand 1
PFS	Progress-free survival
PGE2	Prostaglandin E2
PI3K	Phosphoinositide-3-kinase
PIGF	Placental growth factor
PLCγ	Phospholipase C gamma
RTK	Receptor tyrosine kinase
SDF-1α	Stromal-cell-derived factor 1 alpha
TAM	Tumor associated macrophage
TGF-β	Transforming growth factor beta
TKI	Tyrosine kinase inhibitor
TMB	Tumor burden
TME	Tumor microenvironment
TPS	Tumor proportion score
Tregs	Regulatory T cells
VCAM1	Vascular cell adhesion protein 1
VEGF	Vascular endothelial growth factor
VEGFR	Vascular endothelial growth factor receptor